Keyphrases
After Surgery
24%
Assessment Thresholds
21%
Autoimmune Thyroiditis
21%
Body Mass Index
30%
Bone Mineral Density
73%
Cardiac Failure
21%
Chilean
30%
Chilean Women
21%
Clinical Practice
25%
Clinical Presentation
25%
Confidence Interval
33%
Cortisol
21%
Diagnosis Treatment
24%
Endocrinology
42%
Evidence-based
21%
Exercise Capacity
21%
Failure Effects
21%
Familial Hyperparathyroidism
28%
FRAX®
21%
Fulminant Hepatic Failure
21%
Gonadotropin-releasing Hormone
26%
Growth Hormone
28%
Gynecological Endocrinology
21%
Insulin-like
21%
Insulin-like Growth factor-1
31%
Intervention Threshold
21%
Italian Society
21%
Latin American
63%
Latin American Countries
25%
Lumbar Spine
34%
Menopausal Hormone Therapy
21%
Menopause
25%
Multiple Organ Dysfunction Syndrome
21%
Multiple Systems
21%
National Osteoporosis Foundation
60%
Neurohormonal
21%
Odds Ratio
26%
Osteopenia
38%
Osteoporosis
100%
Osteoporotic Fractures
47%
Parathyroid Hormone Levels
28%
Patient Management
42%
Position Paper
35%
Primary Hyperparathyroidism (pHPT)
55%
Primary Hypothyroidism
21%
Thyroid Carcinoma
42%
Ultra-high Risk
42%
Vitamin D
46%
Vitamin D Deficiency
47%
Vitamin D Supplementation
24%
Medicine and Dentistry
Adrenalectomy
21%
Autoimmune Thyroiditis
21%
Biochemical Marker
21%
Bone Density
79%
Bone Remodeling
21%
Capillary Hemangioma
21%
Cell Transplantation
21%
Congestive Heart Failure
21%
Cushing Syndrome
21%
Disease Course
21%
Ectopic Corticotropin Production
21%
Elderly Patient
21%
Endocrinology
21%
Exercise
21%
FRAX
21%
Fulminant Hepatic Failure
21%
Glucocorticoid
21%
Gonadotropin-Releasing Hormone
28%
Granulosa Cell Tumour
21%
Grave's Disease
21%
Growth Hormone
21%
Heart Left Ventricle Function
21%
Hematopoietic Cell
21%
Hormone Determination
28%
Hydrocortisone
21%
Hydroxysteroid Dehydrogenase
21%
Hypercalcaemia
21%
Hypokalemia
21%
Hypovitaminosis D
33%
Interstitial Cell
21%
Isotopes of Calcium
22%
Lumbar Spine
34%
Multiple Organ Dysfunction Syndrome
21%
Neoplasm
36%
Osteopenia
34%
Osteoplasty
21%
Osteoporosis
66%
Parathyroid Carcinoma
21%
Parathyroid Hormone
28%
Postmenopause
25%
Preoperative Treatment
21%
Primary Hyperparathyroidism
35%
Recurrent Disease
21%
Secondary Amenorrhea
21%
Spectroscopy
21%
Thyroid Cancer
21%
Thyroid Carcinoma
42%
Uterine Fibroid
21%
Vitamin D
48%
Vitamin D Deficiency
33%